We are live on ! Find out more
WA

Whitebox Advisors Portfolio holdings

AUM $7.65B
1-Year Est. Return 13.87%
This Fund
S&P 500
This Quarter Est. Return
+1.93%
1 Year Est. Return
+13.87%
3 Year Est. Return
+24.22%
5 Year Est. Return
+33.25%
10 Year Est. Return
+180.55%
AUM
$7.65B
AUM Growth
-$592M
Cap. Flow
-$3.5B
Cap. Flow %
-45.77%
Top 10 Hldgs %
31.69%
Holding
745
New
163
Increased
24
Reduced
37
Closed
79

Sector Composition

Rank Sector Weight
1 Miscellaneous 76.5%
2 Financials 9.04%
3 Healthcare 5.77%
4 Industrials 2.04%
5 Energy 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUMAU
676
SUMA Acquisition Corp Units
SUMAU
-100,000
Closed -$1M
PONOU
677
Pono Capital Four Inc Units
PONOU
-700,000
Closed -$6.99M
BWIV.U
678
Blue Water Acquisition Corp IV Units
BWIV.U
-350,000
Closed -$3.47M
FMACU
679
Future Money Acquisition Corp Units
FMACU
-350,000
Closed -$3.5M
IPFXU
680
Inflection Point Acquisition Corp VI Units
IPFXU
$229M
-56,400
Closed -$571K
QADRU
681
QDRO Acquisition Corp Units
QADRU
-100,000
Closed -$991K
KPET.U
682
KPET Ultra Paceline Corp Units
KPET.U
-200,000
Closed -$2M

Similar funds

Whitebox Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Whitebox Advisors held 745 positions worth $7.65B, down 7.2% from $8.24B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Whitebox Advisors withdrew a net $3.5B in Q2 2026, closing 79 positions and reducing 37 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $52.7M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 81% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Whitebox Advisors opened a new position in Bio-Techne worth $148M.

  • Whitebox Advisors's largest Q2 2026 buy was Bio-Techne: 2,100,001 shares worth $148M.
  • Whitebox Advisors added most to Caesars Entertainment in Q2 2026, an estimated $92.1M increase.
  • Whitebox Advisors's biggest Q2 2026 reduction was Chart Industries, cutting an estimated $137M.
  • Whitebox Advisors fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $52.7M.
  • Whitebox Advisors's ten largest holdings make up 32% of its $7.65B portfolio in Q2 2026.
  • Whitebox Advisors opened 163 new positions and closed 79 in Q2 2026.
  • Whitebox Advisors's portfolio value fell 7.2% quarter-over-quarter to $7.65B.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.